[ad_1]
(AOF) – Guerbet, a global specialist in medical imaging, and Intrasense, a specialist in medical imaging software solutions, announce that Guerbet’s AI algorithm against liver cancer, DUOnco Liver, has obtained CE marking under the new European MDR regulation. Guerbet has launched a new range of solutions whose algorithms will be integrated into Intrasense solutions but also marketed independently. Already installed on initial pilot sites, the Liflow solution continues its development and the integration of new AI algorithms.
DUOnco Liver enables automatic detection, segmentation and measurement of focal liver lesions, providing increased accuracy and significant time savings, essential elements for optimal management of cancer patients.
Intrasense Liflow version 2.0, enhanced by the integration of DUOnc Liver, reflects Intrasense’s commitment to providing state-of-the-art medical imaging solutions that meet the highest standards of radiologists.
[ad_2]
Source link -86